The University of Arizona
Institutional Knowledge Map (KMap)
Picture of Jayati Chakrabarti

Jayati Chakrabarti

Associate Scientific Investigator

Cellular & Molecular Medicine
Map Page
10+ Collaborators
$284.5K / $2.8M Funding
100+ Publications

Research Area

cancer, organoids, gastric cancer, pancreatic cancer, immunotherapy, cell signaling, tumor microenvironment, helicobacter pylori, cushing's disease, injury response, organoid models, targeted therapy, cell biology, gastric, hedgehog signaling, regeneration, gastric epithelium, cancer immunotherapy, gene expression, immune response, inflammation, stem cells, neuroendocrine

    Chart
    Bar chart with 26 bars.
    The chart has 1 X axis displaying Year.
    The chart has 1 Y axis displaying values. Data ranges from 1 to 13.
    End of interactive chart.
    Recent

    1327 Integrated Epigenomic and Gene Expression Analysis Correlates Genetic Characteristics of GH-Secreting Pituitary Adenomas to Clinical Outcomes

    2025

    Pituitary Neuroendocrine Tumor Organoids Generated from Induced Pluripotent Stem Cells Reveal the Dysregulation of Cell Lineage Differentiation in Cushing’s Disease

    2024
    neuroendocrine tumor, stem cells, cushing's disease, organoids

    8773 CD44 Variant Isoforms Expressed Within PAX7/SOX2-Positive Pituitary Neuroendocrine Tumors Attribute to Therapy Resistance and Recurrence of Cushing’s Disease

    2024
    pituitary tumors, cushing's disease, therapy resistance, neuroendocrine tumors

    Tu1211 CABOZANTINIB INCREASES THE EFFICACY OF PEMBROLIZUMAB IN HUMAN PANCREATIC DUCTAL ADENOCARCINOMA ORGANOID COCULTURES

    2024
    cancer immunotherapy, pancreatic cancer, combination therapy, organoid models

    EXTH-73. TARGETING THE CELL ADHESION CLUSTER OF DIFFERENTIATION 44 TRANSMEMBRANE GLYCOPROTEIN SENSITIZES CRANIOPHARYNGIOMAS TO IMMUNOTHERAPY

    2024
    immunotherapy, cancer, cell adhesion, transmembrane proteins, targeted therapy

    166 Development of non-model organoids in animal research: A paradigm shift in in vitro models

    2024
    organoids, animal research, development, paradigm shift

    Su1202 TARGETING THE CD44 VARIANT ISOFORMS USING A NOVEL CDC-LIKE PROTEIN KINASE INHIBITOR TO IMPROVE THE EFFICACY OF STANDARD-OF-CARE THERAPY FOR PANCREATIC DUCTAL ADENOCARCINOMA

    2024
    cancer, targeted therapy, pancreatic cancer, treatment efficacy

    Cabozantinib changes the tumor microenvironment to increase the efficacy of immunotherapy in refractory metastatic pancreatic ductal adenocarcinoma

    2024
    immunotherapy, pancreatic cancer, tumor microenvironment, metastatic cancer

    Cabozantinib changes the landscape of the pancreatic tumor microenvironment and improves the efficacy of pembrolizumab

    2024
    pancreatic cancer, immunotherapy, tumor microenvironment, efficacy

    SAT625 The EGF-TBX19-EGFR Positive Feedback LooRegulates The Expression Of The CD44v9/SLC7A11 Antioxidant System Within Corticotroph Pituitary Neuroendocrine Tumors

    2023
    cancer, gene regulation, neuroendocrine tumors, cell signaling

    • Rachna Shroff

    • Baldassarre Stea

    • Denise Roe

    • Megha Padi

    • Ritu Pandey

    Page 1 of 4

    • Cell Biology Basics

    Jayati Chakrabarti | KMap Profile - Institutional Knowledge Map (KMap)